Close
FINDING CURES TOGETHER<sup>SM</sup>

AACR Annual Meeting 2020

NextGen Stars 

The NextGen Stars program provides an exciting opportunity to increase the visibility of early-career scientists at the AACR Annual Meeting and to support the professional development and advancement of those selected as AACR NextGen Stars.

Now Accepting Applications!
Early-career scientists can apply to give a presentation in a Major Symposium or Advances Session at the AACR Annual Meeting 2020. Speaking slots are limited and are only available to AACR Associate Members and to AACR Active Members who are not above the level of assistant professor or equivalent. Since the debut of this program in 2014, 45 NextGen Stars have given short talks in major sessions. The NextGen Stars program provides an exciting opportunity to increase the visibility of early-career scientists at the AACR Annual Meeting and to support the professional development and advancement of those selected to speak. The deadline to submit an application and a letter of recommendation is 11:59 p.m. ET, Thursday, Oct. 10, 2019.

Submit a NextGen Star Application
Applicants must log onto myAACR. Once logged on, click "Applications/Awards" to be directed to the AACR Online Submission System. Click "View All Activities" to find the 2020 Annual Meeting: NextGen Star Application where you can create your submission. Click the "Create Submissions" button to begin.

Please note that applicants must be an AACR member in good standing (dues paid for the current year). Learn more about membership or contact membership@aacr.org with any questions.

The application deadline is 11:59 p.m. ET, Thursday, Oct. 10, 2019. Applications consist of an extended abstract (limit 8,000 characters), a CV, and a letter of recommendation from a P.I., department head, or another mentor who is familiar with the applicant's work. Only complete applications will be considered. Applicants selected as NextGen Stars for 2020 will receive travel support and complimentary registration for the meeting. No late applications will be considered. 

Letters of Recommendation are due by 11:59 p.m. ET, Thursday, Oct. 10, 2019. Letters of recommendations may be uploaded as a .doc, .docx, or .pdf file. Mentors may support more than one applicant. Letters of recommendation should include the following information:

  • A description of the length of time and the capacity in which the writer has known the applicant.
  • An assessment of the quality of the applicant's performance in his or her current program.
  • A brief summary of the abstract/research submitted by the applicant.
  • An assessment of the applicant's qualifications/experience in presenting research to a large, diverse audience.

Between 8 and 12 applicants will be chosen to give a talk, regardless of the number of applications received.

Selected talks will be added to existing Major Symposia and Advances sessions, based on the subject matter of the abstract. Most talks will be 15 minutes in length plus 5 minutes for discussion, but the assigned length of the talk may vary depending on the session.

The submission of an extended abstract through this application process is completely separate from the submission of a regular abstract for the Annual Meeting. Applicants will be notified of their status by late November. Those who are not selected to give a talk, but still wish to submit an abstract to the Annual Meeting, must submit a separate abstract through the normal abstract submission process by the Dec. 5, 2019, deadline.

Top of page

View the abstracts of the NextGen Stars' presentations from the AACR Annual Meeting 2019:

Wendy Béguelin, PhD
Assistant Professor of Pharmacology
Weill Cornell Medical College

The role of EZH2 gain of function mutations in lymphomagenesis

Special Session
NextGen Stars Spotlight 1: Genetics and Immunology
Sunday, March 31, 2019


Laura W. Bowers, PhD
Assistant Professor
Purdue University

Obesity-associated leptin signaling promotes chemotherapy resistance in triple-negative breast cancer: The role of tumor-initiating cell enrichment
 
Major Symposium
Obesity and Cancer: When Systemic Metabolism Meets Cell Metabolism
Sunday, March 31, 2019


Nina J. Chu, PhD
Postdoctoral Fellow
Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center


Advances in Organ Site Research
Advances in Pancreatic Cancer
Monday, April 1, 2019


Cosimo Commisso, PhD
Assistant Professor
Cancer Center Sanford Burnham
Prebys Medical Discovery Institute

Regulation of nutrient stress-induced macropinocytosis in pancreatic cancer
 
Special Session
NextGen Stars Spotlight 2: Site-Specific Cancers
Monday, April 1, 2019

Greg M. Delgoffe, PhD
Assistant Professor, Immunology
University of Pittsburgh

Reprogramming tumor microenvironment metabolism to improve immunotherapy
 
Major Symposium
Defining Systemic Tumor-host Communication in Cancer Progression and Therapy Responses
Monday, April 1, 2019

Ann-Kathrin Eisfeld, MD
Fellow, Physician-Scientist Training Program Hematology/Medical Oncology
Ohio State University

Revealing the molecular landscape and associated prognostic implications in patients with acute myeloid leukemia
 
Special Session
NextGen Stars Spotlight 1: Genetics and Immunology
Sunday, March 31, 2019


Andreana N. Holowatyj, PhD, MS
NIH/NHGRI T32 Ruth L. Kirschstein NRSA Postdoctoral Fellow, Genomic Medicine
Huntsman Cancer Institute, University of Utah

Multi-omics analysis reveals a distinct molecular phenotype in patients with young-onset colorectal cancer

Special Session
NextGen Stars Spotlight 2: Site-Specific Cancers
Monday, April 1, 2019


Benjamin Izar, MD, PhD
Clinical Fellow
Dana-Farber Cancer Institute

Development of therapeutic strategies by resolving the tumor ecosystem

Major Symposium
The Next Generation of Precision Cancer Medicine: Recognizing and Exploiting the Complexity
Monday, April 1, 2019


Michalina Janiszewska, PhD
Assistant Professor, Molecular Medicine
The Scripps Research Institute Florida

Divergent resistance mechanisms to HER2-targeted therapies in breast cancer

Special Session
NextGen Stars Spotlight 2: Site-Specific Cancers
Monday, April 1, 2019


Ashish A. Kulkarni, PhD
Assistant Professor, Chemical Engineering
University of Massachusetts Amherst

Immunotheranostic probes for monitoring cancer immunotherapy response

Advances in Diagnostics and Therapeutics
Molecular Imaging for Cancer Immunotherapy
Tuesday, April 2, 2019


Yiting Lim, PhD
Postdoctoral Fellow
Fred Hutchinson Cancer Research Center

Functional analysis of 5’ UTR mutations in prostate cancer reveal dynamic regulation of clinically relevant gene networks

Special Session
NextGen Stars Spotlight 2: Site-Specific Cancers
Monday, April 1, 2019


David Liu, MD
Fellow
Dana-Farber Cancer Institute/Massachusetts General Hospital

Dissecting genomic correlates of response and resistance to chemotherapy in bladder cancer through clinical computational oncology

Major Symposium
Convergence of Artificial Intelligence, Big Data, and Prediction in Cancer
Tuesday, April 2, 2019


Faruk Mohammed, MS
Graduate Student
Ahmadu Bello University

Prostate cancer risk factors and genomic characterization in West African Black men using epidemiology and NGS: Findings from the CaPTC

Advances in the Science of Cancer Health Disparities
The Science of Cancer Health Disparities
Sunday, March 31, 2019


Tamara Ouspenskaia, PhD
Postdoctoral Fellow
Broad Institute of MIT and Harvard

Expanding the immunopeptidome with ribosome profiling

Special Session
NextGen Stars Spotlight 1: Genetics and Immunology
Sunday, March 31, 2019


Ferdinandos Skoulidis, MD, PhD
Assistant Professor, Thoracic Head and Neck Medical Oncology
The University of Texas MD Anderson Cancer Center

Inactivating STK11/LKB1 genomic alterations are a major driver of primary resistance to PD-1 axis blockade in non-squamous non-small cell lung cancer

Major Symposium
Dharma Master Jiantai Symposium in Targeted Therapy: Systematic Elucidation of Nononcogene Targets
Monday, April 1, 2019


Liuqing Yang, PhD
Assistant Professor, Department of Molecular and Cellular Oncology
The University of Texas MD Anderson Cancer Center

Long noncoding RNA-directed antigenicity loss suppresses immunosurveillance

Special Session
NextGen Stars Spotlight 1: Genetics and Immunology
Sunday, March 31, 2019

Top of page